Carmell Corporation (CTCX)

$0.53 -0.05 (-8.66%)
Market Cap 10.98M
Revenue (ttm) 0.00
Net Income (ttm) -15.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 273,600
Avg Vol 8,413,799
Day's Range N/A - N/A
Shares Out 20.91M
Stochastic %K 51%
Beta 0.30
Analysts Strong Buy
Price Target N/A

Latest News on CTCX

Carmell Announces Closing of Elevai Skincare Acquisition

Jan 16, 2025, 8:00 AM EST - 3 days ago

Carmell Announces Closing of Elevai Skincare Acquisition

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

Jan 3, 2025, 8:00 AM EST - 16 days ago

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Jan 2, 2025, 8:00 AM EST - 17 days ago

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

Dec 24, 2024, 8:30 AM EST - 26 days ago

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Jul 29, 2024, 8:30 AM EDT - 6 months ago

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Carmell Announces Successful Closing of $3.0 Million Private Placement

Apr 11, 2024, 4:30 PM EDT - 10 months ago

Carmell Announces Successful Closing of $3.0 Million Private Placement

Carmell Announces $3.0 Million Private Placement

Apr 4, 2024, 8:30 AM EDT - 10 months ago

Carmell Announces $3.0 Million Private Placement

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

Mar 27, 2024, 9:15 AM EDT - 10 months ago

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

Mar 20, 2024, 4:39 PM EDT - 10 months ago

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

Mar 18, 2024, 3:16 PM EDT - 10 months ago

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

Feb 26, 2024, 8:30 AM EST - 11 months ago

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

Nov 16, 2023, 8:30 AM EST - 1 year ago

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine

Sep 12, 2023, 12:35 PM EDT - 1 year ago

Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

Sep 5, 2023, 6:03 PM EDT - 1 year ago

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

Aug 9, 2023, 3:41 PM EDT - 1 year ago

Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company

Jul 27, 2023, 7:00 AM EDT - 1 year ago

Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

Jul 14, 2023, 3:12 PM EDT - 1 year ago

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

Jun 27, 2023, 7:00 AM EDT - 1 year ago

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination